1 domain / 2 areas / 2 specializations
Psygen
Psygen is a Canadian GMP-certified active pharmaceutical ingredient (API) manufacturer specialising in psychedelic compounds for clinical research. Founded in 2019 and based in Calgary, Alberta, the company produces pharmaceutical-grade psilocybin, LSD, MDMA, DMT, ibogaine, and 5-MeO-DMT under DEA- and Health Canada-compliant conditions, supplying clinical trial sponsors and research institutions. Psygen raised $5.5M to expand its GMP manufacturing capabilities.
Manufacturing Snapshot
Psychedelic-Focused ManufacturerScope & Capabilities
Supply Use Cases
GxP / Compliance
Facilities & Access
Purpose-built 17,000 sq ft facility with dedicated process R&D and API synthesis infrastructure.
Manufacturing DetailsSupported Substances
Psychedelic and neuroplastogen APIs, including LSD, MDMA, and psilocybin-class compounds.
Manufacturing Sources
Quick Facts
- Type
- Private Biotech
- Founded
- 2019
- Website
- Visit